®
October 2014
Rev. No: 01
HLA-B*27 – unit dose single well
101.911-96/96u
49V
Visit www.olerup-ssp.com
for “Instructions for Use”
(IFU) and detailed Product
Inserts
Gel Documentation Form and Worksheet
HLA-B*27 unit dose single well (101.911-96/96u)
Lot: 49V
Name:____________________
Test Date: ________
Sample ID:________________
Tested By: ____
Expiry Date:
2016-August-01
_
Review Date:_______________
_____
Reviewed By:_______________
DNA Conc.(ng/ul):_________
Gel Picture
PHOTO DOCUMENT
Well No.
1
ICB
430
Am pS
145
205
Well No.
Specific
Reaction
1
‘ICB’ Internal Control Band,
‘AmpS’ Amplicon size
Interpretation:_______________
Failed lanes:
_________
Comments:
___________________
Notes: Product sizes are approximate. For detailed information, see the lot-specific Specificity Table and Interpretation Table.
This table is intended as a guide. For interpretation always use the Interpretation Table and/or Specificity Table.
Olerup SSP AB
Franzengatan 5
SE-112 51 Stockholm
Sweden
For In Vitro Diagnostic Use
Page 1 of 2
®
October 2014
Rev. No: 01
HLA-B*27 – unit dose single well
101.911-96/96u
49V
Well No.
1
HLA-B allele 1,2
*27:01-27:05:22, 27:05:24-27:21, 27:2427:28, 27:30-27:74, 27:76, 27:78-27:84,
27:86-27:117
B*07:197, B*44:97, B*49:26
Well No.
Visit www.olerup-ssp.com
for “Instructions for Use”
(IFU) and detailed Product
Inserts
1
1
1
1The
primers in this kit do not amplify the B*27:05:23, B*27:23, B*27:29, B*27:75, B*27:77 and B*27:85 alleles.
Due to the sharing of sequence motifs between HLA-B alleles the B*07:197, B*44:97 and B*49:26 is amplified by primer
mix 1.
2Alleles that have been deleted from or renamed in the official WHO HLA Nomenclature up to and including the last
IMGT/HLA database release can be retrieved from web page http://hla.alleles.org/alleles/deleted.html.
Change in revision R01 compared to R00:
1.
The expiry date has been corrected.
Olerup SSP AB
Franzengatan 5
SE-112 51 Stockholm
Sweden
For In Vitro Diagnostic Use
Page 2 of 2